Amplia Therapeutics Ltd
ASX:ATX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amplia Therapeutics Ltd
ASX:ATX
|
AU |
|
Adecoagro SA
NYSE:AGRO
|
LU |
|
Financial Institutions Inc
NASDAQ:FISI
|
US |
|
N
|
Nano Co Ltd
KOSDAQ:187790
|
KR |
|
Brundage-Bone Concrete Pumping Holdings Inc
NASDAQ:BBCP
|
US |
|
C
|
Cyclopharm Ltd
ASX:CYC
|
AU |
|
F
|
Frasers Property Thailand Industrial Freehold & Leasehold REIT
SET:FTREIT
|
TH |
|
R
|
Rayence Co Ltd
KOSDAQ:228850
|
KR |
|
Samsara Inc
NYSE:IOT
|
US |
|
Pearson PLC
LSE:PSON
|
UK |
|
RHB Bank Bhd
KLSE:RHBBANK
|
MY |
|
Resources Connection Inc
NASDAQ:RGP
|
US |
|
Elbit Systems Ltd
TASE:ESLT
|
IL |
|
Aker Carbon Capture ASA
OSE:ACC
|
NO |
|
Genco Shipping & Trading Ltd
NYSE:GNK
|
US |
|
Brickability Group PLC
LSE:BRCK
|
UK |
|
Fundamenta Real Estate AG
SIX:FREN
|
CH |
|
B
|
BuzzFeed Inc
NASDAQ:BZFD
|
US |
|
WEC Energy Group Inc
NYSE:WEC
|
US |
|
Restaurant Brands International Inc
NYSE:QSR
|
CA |
Bankruptcy Probability
Amplia Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amplia Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Amplia Therapeutics Ltd
ASX:ATX
|
56.4m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amplia Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amplia Therapeutics Ltd has total debt of 297.6k AUD. This includes both short-term (0 AUD) and long-term (297.6k AUD) debt.
You can find a full breakdown on its Balance Sheet.
